For the quarter ending 2026-03-31, MNPR had -$91,150,360 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net income (loss) | 4,623,049 | -3,437,601 | -5,078,498 |
| Stock-based compensation expense | -2,040,793 | 1,099,210 | 2,634,563 |
| Net amortization of investment discounts and premiums | 799,634 | - | - |
| Other current assets | -506,960 | 107,242 | 586,757 |
| In-process research and development accrued expenses | -3,000,000 | 0 | 3,000,000 |
| Accounts payable, accrued expenses and other current liabilities | 63,326 | 355,101 | -705,565 |
| Operating lease right-of-use assets and liabilities, net | -4,405 | 0 | 4,430 |
| Net cash provided by (used in) operating activities | 5,357,313 | -2,090,532 | -6,740,687 |
| Purchase of short-term investments | 31,972,991 | 5,726,027 | 3,138,534 |
| Maturities of short-term investments | 27,654,000 | 3,600,000 | 4,000,000 |
| Net cash provided by (used in) investing activities | -4,318,991 | -2,126,027 | 861,466 |
| Cash proceeds from the sales of common stock under a capital on demandtm sales agreement | - | 0 | 0 |
| Taxes paid related to net share settlement of vested restricted stock units | -634,044 | 381,563 | 452,684 |
| Cash proceeds from the issuance of stock upon exercise of stock options | -20,371 | 214 | 20,157 |
| Net proceeds from issuance of common stock and concurrent issuance of pre-funded warrants upon public offering, net of offering costs | - | 127,772,915 | - |
| Repurchase of common stock | - | 34,999,957 | - |
| Net cash provided by (used in) financing activities | -92,159,285 | 92,391,609 | -432,527 |
| Effect of exchange rate and valuation changes on cash equivalents | -29,399 | 376 | -2,605 |
| Net increase (decrease) in cash and cash equivalents | -91,150,360 | 88,175,424 | -6,314,353 |
| Cash and cash equivalents at beginning of period | 127,677,360 | 45,816,289 | - |
| Cash and cash equivalents at end of period | 52,544,263 | 127,677,360 | - |